carbostyril has been researched along with Pneumococcal Infections in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 13 (36.11) | 18.2507 |
2000's | 16 (44.44) | 29.6817 |
2010's | 6 (16.67) | 24.3611 |
2020's | 1 (2.78) | 2.80 |
Authors | Studies |
---|---|
Kim, EY; Kim, GR; Kim, SH; Shin, JH | 1 |
Cao, YR; Chen, YC; Guo, QL; Hu, JL; Huang, J; Liang, W; Liu, XF; Wu, XJ; Zhang, J; Zhang, SJ; Zhang, YY; Zhao, M; Zhu, DM | 1 |
Hoshino, T; Ishiwada, N; Naito, S; Ohkusu, M; Takaya, A; Takeuchi, N; Yamamoto, T | 1 |
Aguilar, L; Aragoneses-Fenoll, L; Fenoll, A; Giménez, MJ; Granizo, JJ; Mendez, C; Tarragó, D | 1 |
Guo, HY; Guo, Q; Liu, BQ; Liu, ML; Sun, LY; Wang, XY; Wang, YC | 1 |
Fujii, N; Ohkoshi, Y; Yokota, S | 1 |
Ichiyama, S; Imai, S; Ishida, T; Ito, Y; Mishima, M; Osawa, M | 1 |
Galanakis, E; Maraki, S; Samonis, G | 1 |
Ardanuy, C; Calatayud, L; Cubero, M; de la Campa, AG; Fenoll, A; Liñares, J; Rolo, D | 1 |
Araki, N; Harada, Y; Hasegawa, H; Kamihira, S; Kohno, S; Matsukawa, Y; Migiyama, Y; Morinaga, Y; Nagaoka, K; Yamada, K; Yanagihara, K | 1 |
Hoban, DJ; Nichol, K; Noreddin, A; Smith, H; Walkty, A; Zhanel, GG | 1 |
Banevicius, M; Mattoes, HM; Nicolau, DP; Nightingale, CH; Xuan, D | 1 |
Bellyou, T; Hoban, DJ; Low, DE; Nichol, KA; Palatnick, L; Zhanel, GG | 1 |
Almaraz, F; Baquero, F; Cantón, R; del Campo, R; Loza, E; Morosini, MI | 1 |
Kinzig-Schippers, M; Kolbert, M; Machka, K; Malerczyk, C; Shah, PM; Sörgel, F | 1 |
Fukuda, Y; Higashiyama, Y; Hirakata, Y; Kohno, S; Miyazaki, Y; Mizuta, Y; Ohno, H; Tashiro, T; Tomono, K; Tsukamoto, K; Yanagihara, K | 1 |
Bachhawat, R; Deziel, MR; Drusano, GL; Jumbe, NL; Liu, W; Louie, A; Miller, MH; Tam, VH | 1 |
Adam, HJ; Decorby, MR; Hoban, DJ; Karlowsky, K; Schurek, KN; Vashisht, R; Weshnoweski, B; Zhanel, GG | 1 |
Baquero, F; García-Rey, C; Martín-Herrero, JE | 1 |
Watanuki, Y | 1 |
Morrissey, I; Smith, JT | 1 |
Nakabayashi, M; Niki, Y; Soejima, R; Tamada, S | 1 |
Dupont, H; Gachot, B; Regnier, B; Souweine, B; Timsit, JF; Wolff, M | 1 |
Destache, CJ; Pakiz, CB; Stoysich, AM | 1 |
Johnson, AP; Parsons, T; Warner, M | 1 |
Jones, RN; Pfaller, MA | 1 |
Goldsmith, CE; Moore, JE; Murphy, PG | 1 |
Miyazaki, S; Tateda, K; Tomizawa, H; Yamaguchi, K | 1 |
Brück, W; Chen, V; Dalhoff, A; Kohlsdorfer, C; Nau, R; Schmidt, H; Schneider, O; Stuertz, K; Trostdorf, F | 1 |
Bensch, G; Chodosh, S; DeAbate, CA; Harper, L; Henry, D; Jubran, A; Talbot, GH; Tipping, D | 1 |
Deschilder, I; Liekens, K; Lontie, M | 1 |
Boos, M; Fluit, AC; Hafner, D; Jagusch, H; Mayer, S; Schmitz, FJ | 1 |
Fluit, AC; Milatovic, D; Schmitz, FJ; Verhoef, J | 1 |
Bell, JM; Jones, RN; Turnidge, JD | 1 |
Azoulay-Dupuis, E; Bergogne-Bérézin, E; Pocidalo, JJ; Vallée, E | 1 |
Albrecht, HA; Beskid, G; Chan, KK; Christenson, JG; Cleeland, R; Deitcher, KH; Georgopapadakou, NH; Keith, DD; Pruess, DL; Sepinwall, J | 1 |
2 review(s) available for carbostyril and Pneumococcal Infections
Article | Year |
---|---|
Antibiotic consumption and generation of resistance in Streptococcus pneumoniae: the paradoxical impact of quinolones in a complex selective landscape.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Pneumococcal Infections; Quinolones; Selection, Genetic; Spain; Streptococcus pneumoniae | 2006 |
[Prevalence and treatment for antibiotic-resistant bacteria in respiratory infection].
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Haemophilus Infections; Haemophilus influenzae; Humans; Macrolides; Mutation; Penicillin Resistance; Penicillin-Binding Proteins; Pneumococcal Infections; Prevalence; Pseudomonas Infections; Quinolones; Respiratory Tract Infections; Streptococcus pneumoniae | 2007 |
2 trial(s) available for carbostyril and Pneumococcal Infections
Article | Year |
---|---|
Serum bactericidal activity of gemifloxacin versus clarithromycin against Streptococcus pneumoniae with different susceptibility to quinolones.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Clarithromycin; Cross-Over Studies; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Gemifloxacin; Humans; Male; Middle Aged; Naphthyridines; Pneumococcal Infections; Quinolones; Streptococcus pneumoniae | 2004 |
Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Chlamydia Infections; Chlamydophila pneumoniae; Chronic Disease; Cough; Double-Blind Method; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Moraxella catarrhalis; Neisseriaceae Infections; Ofloxacin; Placebos; Pneumococcal Infections; Quinolones; Sputum; Staphylococcal Infections; Treatment Outcome | 1998 |
32 other study(ies) available for carbostyril and Pneumococcal Infections
Article | Year |
---|---|
Characteristics of Clonal Complex Changes and Quinolone Resistance-Determining Region Mutations of Levofloxacin-Resistant
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Pneumococcal Infections; Quinolones; Streptococcus pneumoniae | 2022 |
Pharmacokinetics and pharmacodynamics of nemonoxacin against Streptococcus pneumoniae in an in vitro infection model.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Colony Count, Microbial; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Pneumococcal Infections; Quinolones; Streptococcus pneumoniae | 2013 |
Emergence of quinolone-resistant strains in Streptococcus pneumoniae isolated from paediatric patients since the approval of oral fluoroquinolones in Japan.
Topics: Anti-Bacterial Agents; beta-Lactamases; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Fluoroquinolones; Genes, Bacterial; Humans; Japan; Male; Pneumococcal Infections; Quinolones; Streptococcus pneumoniae | 2017 |
Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?
Topics: Adult; Anti-Bacterial Agents; Child; Drug Resistance, Bacterial; Erythromycin; Heptavalent Pneumococcal Conjugate Vaccine; Humans; Microbial Sensitivity Tests; Penicillins; Pneumococcal Infections; Pneumococcal Vaccines; Quinolones; Serotyping; Spain; Streptococcus pneumoniae | 2008 |
[Synthesis and antibacterial activity of 7-(3-amino-4-alkoxyimino-1 -piperidyl) -quinolones].
Topics: Animals; Anti-Bacterial Agents; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Molecular Structure; Pneumococcal Infections; Quinolones; Random Allocation; Staphylococcal Infections | 2008 |
Susceptibility and bactericidal activity of 8 oral quinolones against conventional-fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Japan; Microbial Sensitivity Tests; Microbial Viability; Pneumococcal Infections; Quinolones; Streptococcus pneumoniae | 2009 |
Molecular characterization of quinolone resistance-determining regions and their correlation with serotypes and genotypes among Streptococcus pneumoniae isolates in Japan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; DNA Gyrase; DNA Mutational Analysis; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Genotype; Humans; Japan; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Pneumococcal Infections; Quinolones; Sequence Analysis, DNA; Streptococcus pneumoniae; Young Adult | 2010 |
Serotypes and susceptibilities of paediatric clinical isolates of Streptococcus pneumoniae in Crete, Greece, before and after the heptavalent pneumococcal conjugate vaccine.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactams; Child; Child, Preschool; Chloramphenicol; Clindamycin; Greece; Heptavalent Pneumococcal Conjugate Vaccine; History, 21st Century; Humans; Immunization Programs; Macrolides; Microbial Sensitivity Tests; Pneumococcal Infections; Pneumococcal Vaccines; Quinolones; Serotyping; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vaccines, Conjugate; Vancomycin | 2010 |
Trends of invasive serotype 6C pneumococci in Spain: emergence of a new lineage.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; DNA, Bacterial; Drug Resistance, Bacterial; Female; Genotype; Heptavalent Pneumococcal Conjugate Vaccine; Humans; Infant; Infant, Newborn; Macrolides; Male; Middle Aged; Multilocus Sequence Typing; Pneumococcal Infections; Pneumococcal Vaccines; Polymorphism, Restriction Fragment Length; Quinolones; Serotyping; Spain; Streptococcus pneumoniae; Tetracycline; Young Adult | 2011 |
Molecular characterization of quinolone-insensitive Streptococcus pneumoniae isolates from Japanese patients.
Topics: Anti-Bacterial Agents; DNA Mutational Analysis; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Japan; Microbial Sensitivity Tests; Molecular Typing; Mutation; Pneumococcal Infections; Polymerase Chain Reaction; Quinolones; Streptococcus pneumoniae | 2013 |
Molecular characterization of fluoroquinolone resistant Streptococcus pneumoniae clinical isolates obtained from across Canada.
Topics: Anti-Bacterial Agents; Canada; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Pharmacogenetics; Pneumococcal Infections; Polymerase Chain Reaction; Quinolones; Sensitivity and Specificity; Streptococcus pneumoniae | 2003 |
Pharmacodynamics of a novel des-F(6)-quinolone, BMS-284756, against Streptococcus pneumoniae in the thigh infection model.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Disease Models, Animal; Fluoroquinolones; Indoles; Mice; Mice, Inbred CBA; Mice, Inbred ICR; Microbial Sensitivity Tests; Pneumococcal Infections; Protein Binding; Quinolones; Streptococcus pneumoniae; Thigh | 2003 |
Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Canada; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fluoroquinolones; Humans; Indoles; Ketolides; Longitudinal Studies; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Pneumococcal Infections; Quinolones; Respiratory Tract Infections; Streptococcus pneumoniae; Tigecycline | 2003 |
Fluoroquinolone-resistant Streptococcus pneumoniae in Spain: activities of garenoxacin against clinical isolates including strains with altered topoisomerases.
Topics: Anti-Infective Agents; DNA Gyrase; DNA Topoisomerases; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Genes, Bacterial; Humans; Indoles; Methyltransferases; Microbial Sensitivity Tests; Pneumococcal Infections; Prospective Studies; Quinolones; Reverse Transcriptase Polymerase Chain Reaction; Spain; Streptococcus pneumoniae | 2003 |
In vivo efficacies and pharmacokinetics of DX-619, a novel des-fluoro(6) quinolone, against Streptococcus pneumoniae in a mouse lung infection model.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Disease Models, Animal; Lung Diseases; Mice; Mice, Inbred ICR; Pneumococcal Infections; Pyrrolidines; Quinolones; Streptococcus pneumoniae | 2006 |
Quinolone efflux pumps play a central role in emergence of fluoroquinolone resistance in Streptococcus pneumoniae.
Topics: Animals; Anti-Infective Agents; Carrier Proteins; Drug Resistance, Bacterial; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Models, Animal; Models, Biological; Pneumococcal Infections; Quinolones; Streptococcus pneumoniae | 2006 |
Comparative in vitro activity of PGE 9262932 and fluoroquinolones against Canadian clinical Streptococcus pneumoniae isolates, including molecularly characterized ciprofloxacin-resistant isolates.
Topics: Anti-Bacterial Agents; Canada; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Genotype; Humans; Microbial Sensitivity Tests; Mutation; Pneumococcal Infections; Quinolones; Streptococcus pneumoniae | 2006 |
Activity of new 4-quinolones in combination with erythromycin or tetracycline against S. pneumoniae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Drug Therapy, Combination; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Ofloxacin; Pneumococcal Infections; Quinolones; Spiro Compounds; Streptococcus pneumoniae; Tetracycline | 1995 |
Sparfloxacin, a new generation fluoroquinolone against S. pneumoniae respiratory infections.
Topics: Animals; Anti-Infective Agents; Fluoroquinolones; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pneumococcal Infections; Quinolones; Respiratory Tract Infections; Streptococcus pneumoniae; Survival | 1995 |
Torsades de pointe probably related to sparfloxacin.
Topics: Anti-Infective Agents; Female; Fluoroquinolones; Humans; Mastoiditis; Middle Aged; Otitis Media; Pneumococcal Infections; Quinolones; Torsades de Pointes | 1996 |
Pharmacodynamics and pharmacokinetics of A-80556 using microdialysis in a Streptococcus pneumoniae meningitis model.
Topics: Animals; Anti-Infective Agents; Disease Models, Animal; Fluoroquinolones; Meningitis, Bacterial; Microbial Sensitivity Tests; Microdialysis; Pneumococcal Infections; Quinolones; Rabbits; Streptococcus pneumoniae | 1996 |
Activity of grepafloxacin against respiratory isolates of Streptococcus pneumoniae.
Topics: Anti-Infective Agents; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Piperazines; Pneumococcal Infections; Quinolones; Respiratory Tract Infections; Sputum; Streptococcus pneumoniae | 1997 |
Comparative antistreptococcal activity of two newer fluoroquinolones, levofloxacin and sparfloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Humans; In Vitro Techniques; Levofloxacin; Ofloxacin; Pneumococcal Infections; Quinolones; Streptococcal Infections; Streptococcus; Streptococcus pneumoniae | 1997 |
Pneumococcal resistance in the UK.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple; Fluoroquinolones; Humans; Macrolides; Microbial Sensitivity Tests; Northern Ireland; Ofloxacin; Oxacillin; Penicillin Resistance; Penicillins; Piperazines; Pneumococcal Infections; Quinolones; Retrospective Studies; Streptococcus pneumoniae; Tetracycline | 1997 |
Antibacterial activity of AM-1155 against penicillin-resistant Streptococcus pneumoniae.
Topics: Animals; Anti-Infective Agents; Fluoroquinolones; Gatifloxacin; Male; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Penicillin Resistance; Piperazines; Pneumococcal Infections; Quinolones; Streptococcus pneumoniae; Survival Rate | 1998 |
Moxifloxacin in the therapy of experimental pneumococcal meningitis.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Colony Count, Microbial; Disease Models, Animal; Fluoroquinolones; Meningitis, Pneumococcal; Moxifloxacin; Pneumococcal Infections; Quinolines; Quinolones; Rabbits; Streptococcus pneumoniae | 1998 |
In vitro activity of newer quinolones on Streptococcus pneumoniae isolated from outpatients.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Cefuroxime; Cephalosporins; Doxycycline; Drug Therapy, Combination; Fluoroquinolones; Humans; Naphthyridines; Ofloxacin; Outpatients; Penicillin G; Penicillins; Piperazines; Pneumococcal Infections; Quinolones; Roxithromycin; Streptococcus pneumoniae | 1998 |
Induction of in vitro resistance to BMS-284756 by Streptococcus pneumoniae.
Topics: Anti-Infective Agents; Culture Media; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Indoles; Microbial Sensitivity Tests; Mutation; Pneumococcal Infections; Quinolones; Streptococcus pneumoniae | 2001 |
Treatment options for Streptococcus pneumoniae strains resistant to macrolides, tetracycline, quinolones, or trimethoprim/sulfamethoxazole.
Topics: Drug Resistance, Multiple; Humans; Macrolides; Microbial Sensitivity Tests; Pneumococcal Infections; Quinolones; Sensitivity and Specificity; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2001 |
Antimicrobial resistance trends in community-acquired respiratory tract pathogens in the Western Pacific Region and South Africa: report from the SENTRY antimicrobial surveillance program, (1998-1999) including an in vitro evaluation of BMS284756.
Topics: Anti-Infective Agents; Asia; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Indoles; Microbial Sensitivity Tests; Moraxella catarrhalis; Neisseriaceae Infections; Pneumococcal Infections; Population Surveillance; Prevalence; Quinolones; Respiratory Tract Diseases; South Africa; Streptococcus pneumoniae | 2002 |
Pharmacokinetics of four fluoroquinolones in an animal model of infected lung.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Fluoroquinolones; Lung Diseases; Mice; Mice, Inbred Strains; Ofloxacin; Pneumococcal Infections; Quinolones; Streptococcus pneumoniae | 1991 |
Cephalosporin 3'-quinolone esters with a dual mode of action.
Topics: Animals; Anti-Infective Agents; Cefotaxime; Cephalosporins; Chemical Phenomena; Chemistry; Ciprofloxacin; Enterobacter; Escherichia coli Infections; Fleroxacin; Fluoroquinolones; Hydrolysis; Mice; Molecular Structure; Pneumococcal Infections; Prodrugs; Quinolones; Rats; Staphylococcus aureus; Structure-Activity Relationship | 1990 |